Dissertation > Excellent graduate degree dissertation topics show

Expression and Clinical Significance of CD8~+CD28~- Regulatory T Cells in Idiopathic Thrombocytopenic Purpura and Acute Leukemia

Author: LiYuBing
Tutor: LiuYanXiang
School: Yan'an University
Course: Internal Medicine
Keywords: CD8~+T cells CD8~+CD28~-Treg cells ITP AL FCM PLT WBC
CLC: R554.6
Type: Master's thesis
Year: 2011
Downloads: 21
Quote: 0
Read: Download Dissertation

Abstract


[Objective] CD8+CD28-Regulatory T cell belongs to an important subset of CD8+Treg cells. To be more detail, it is a mature T cell subset, which has the specific suppression of effect antigen of negative regulation, and can control its self-reactive cells. In recent years, CD8+CD28-Treg cell has being an important part of the study about the relationship and balance between the immune response and immune tolerance. It may involve in the incidence of autoimmune diseases and tumor. Through this study is to observe quantity and expression of peripheral blood CD8+CD28-Treg cells and CD8+T cells of Idiopathic Thrombocytopenic Purpura(ITP) and Acute Leukemia(AL) patients, discuss them in the relationship of ITP and AL; Through comparing the situation before and after treatment with the normal group, discuss law and clinical significance of the variation of disease incidence in ITP and AL by change of peripheral blood CD8+CD28-Treg cells and CD8+T cells; provide the possible ideas and theories for pathogenesis and treatment of immunology.[Objects and Methods]1. Study objects: Collect newly diagnosed ITP and AL patients from Blood Immunology of Yan’an university affiliated hospital in December 2009 February 2011. There are 98 cases. All cases were confirmed according to the third edition "Blood Disease Diagnosis and Treatment Standard”standardization of Zhang Zhinan and others in 2007 by physicians of Blood Immunology, excluded other diseases. Control group 30 cases were normally healthy subjects; the median age was 31.0(5-50) years, male 19 cases, and female11 cases. There was no significant difference with the composition of the experimental group in the age and gender. ITP 35 cases in study have different degree and significant bleeding in the clinic,which were collected from the outpatient and inpatient. The median age was 40.0 (3-80) years, male 23 cases, and female 12 cases, there were 20 cases with platelet for (20-50)×109 / L in the treatment and 15 cases with platelet <20×109 / L. Firstly they received glucocorticoids after the diagnosis. 12 of them received equivalent dose methylprednisolone pulse therapy, 9 of them received the treatment of combination with high dose gamma globulin. After treatment platelets restored, they changed to take orally prednisone. 33 cases obtained efficient treatment. The blood of 2 cases was improved markedly after the treatment by above methods, but they relapsed in the short term when the hormone was diminished a little. In such situation, the spleen was taken off finally. The group detected peripheral blood CD8+CD28-Treg cells and CD8+T cells when they were diagnosed and treated to normal platelets after 4 weeks, and compared with the normal group respectively. There were 63 cases AL patients, who were collected from the hospital, among them, male 36 cases, and female 27 cases. The median age was 25.0(2-81) years. All cases were determined by bone marrow cytology、cytochemistry and flow cytometry immunophenotype. While Acute Lymphoblastic Leukemia (ALL) patients also need to be checked by using fluorescent hybridization fusion gene BCR / ABL, M3 by using PML-RARαand M2 by using AML1-ETO. Among these 63 cases, 33 cases were Diagnosed ALL, 1 case mixed type, 29 cases Acute Non-Lymphocytic Leukemia(ANLL), 3 cases M1, 5 cases M2, 8 cases M3, 7 cases M4, 4 cases M5, 2 cases M6. ALL were released by using the chemotherapies of VMP、VDLP、CEA respectively. 1 case fusion gene BCR-ABL (+) patient added to take imatinibmesylate; M3 PML-RARα(+) patients were done chemotherapy , taking ATRA and As2O3. Other ANLL patients were released by using the chemotherapies of MA (DA or HA)、MEA (or DEA). After the second course, 39 cases were released complete remission (CR) and 21 cases partial remission (PR). 1 case died during the first course of chemotherapy, 1 case gave up and 1 case died after the second course of chemotherapy. 60 cases with complete data were drawn peripheral blood CD8+CD28-Treg cells and CD8+T cells to compare with normal group when diagnosed, done chemotherapy released PR, released CR respectively.2. Methods: Take the fasting blood 7ml with empty stomach in the morning,①Detect quantity and expression of peripheral blood CD8+CD28-Treg cells、CD8+T cells of ITP,AL patients before and after treatment compared with normal group by micro flow cytometry of labeled doors with fluorescence CD3;②Use the Cellquest software to analyze data, record the percentage of cells in each group, diminish non-specificity control group and carry out comprehensive analysis;③Detect platelet(PTL) and white blood cell (WBC)parameters of ITP and AL patients by resistance-type blood cell analyzer provided by the German COULTER JENS company. Operations were strictly carried out in accordance with instructions;④Statistical analysis, use the SPSSl6.0 statistical software , the comparison of distribution that meet the measurement data was checked by independent sample T ; the comparison of distribution that didn’t meet the measurement data was checked by rank sum . Use non-parametric Spearman rank correlation test to straight line correlation analysis. P = 0.05 was the standard.[Results]1. The analysis of peripheral blood CD8+T cells and CD8+CD28-T cells immunophenotype:1.1 Quantity of peripheral blood CD8+T cells and CD8+CD28-T cells of ITP patients before treatment was compared with normal group: CD8+T cells were increased, while CD8+CD28-T cells were decreased significantly, and the differences possessed statistical significance (P <O.05). After treatment, CD8+T cells and CD8+CD28-T cells were compared with those before treatment, CD8 + T cells were decreased. While CD8+CD28-T cells were increased, the differences also possessed statistical significance (P <O.05). After treatment, the quantity of CD8+T cells and CD8+CD28-T cells became normal when they compared with normal group, and there was no significant difference between the two groups. The blood of 2 cases was improved markedly after the treatment by above methods, but they relapsed in the short term when the hormone was diminished a little. In such situation, the spleen was taken off finally. And peripheral blood CD8+CD28-T cells were detected repeatedly, which did not change significantly before and after treatment.1.2 Quantity of peripheral blood CD8+T cells and CD8+CD28-T cell of AL patients before treatment was higher than the normal group, the differences possessed statistical significance (P <O.05). After second treatment quantity of peripheral blood CD8 + T cells, CD8+CD28-T cells of PR and CR patients was lower than those before treatment, CD8+CD28-T cells of CR patients was especially decreased more significantly than PR, the differences of them possessed statistical significance(P <O.05). With the normal group as control, CR tended to be normal and was no significant difference; PR was slightly higher than normal group (P <O.05). 2. The analysis of peripheral blood CD8+CD28-/CD8+T cells immunophenotype:Before treatment CD8+CD28-/CD8+T cell of ITP patients was lower than the normal group, while AL patients was higher than the normal group, the differences possessed statistical significance (P <O.05). After treatment platelets to normal of ITP, and AL reached CR and PR, compared respectively with those before treatment, three groups possessed statistical significance (P <O.05). With the normal group as control, after treatment ITP possessed statistical significance (P <O.05), while AL didn’t possessed statistical significance.3. The correlation analysis of peripheral blood CD8+T cells and CD8+CD28-Treg cells of ITP, AL patients:Though checking between peripheral blood CD8+T cells of ITP, AL patients and CD8+CD28-Treg cells as Spearman rank correlation test showed that: there were no correlation relationship between peripheral blood CD8+ T cells and CD8+CD28-Treg cells in ITP patients, (r = 0.151, P = 0.386); and there was positive correlation relationship in AL patients, (r = 0.857, P = 0.000).4. The correlation analysis of peripheral blood CD8 +T cells, CD8+CD28-Treg cells and quantity of PTLand WBC:Use non-parametric Spearman rank correlation coefficient test result showed that: peripheral blood CD8+T cells, CD8+CD28-Treg cells and quantity of PTL of ITP patients were no correlation relationship; peripheral blood CD8+T cells, CD8+CD28-Treg cells and quantity of WBC of AL were also no correlation relationship, namely, (r =- 0.116, P = 0.507), (r =- -0.082, P = 0.638), (r =- 0.070, P = 0.6051 ), (R =- 0.051, P = 0.704).[Conclusion]1. Expression levels of peripheral blood CD8+CD28-Treg and CD8+T cells may be closely related to the occurrence and development of ITP, and its height may reflect the degree of cellular immune dysfunction and situation of disease activity coercion in ITP, and CD8+CD28-Treg cells may be one of important cell populations that involved in its pathogenesis in the cellular immunity of ITP patients.2. Peripheral blood CD8+CD28-Treg cells and CD8+T cells have some relevance in the pathogenesis of AL. Monitoring the expressive level of its ratio mayhave certain value of clinical guidance in the therapy and prognosis of AL. After treatment the quantity of peripheral blood CD8+CD28-Treg cells in CR patients were lower than PR patients, and tended to be normal. It also showed that cellular immunity was suppressed severely in AL patients.3. Expression levels of peripheral blood CD8+CD28-Treg cells in ITP patients was lower than normal, CD8+T cells was higher than normal; While expression levels of peripheral blood CD8+CD28-Treg cells and CD8+T cells in AL patients was even higher than normal.4. Expressive levels of peripheral blood CD8+CD28-Treg cells in ITP patients was no correlation with CD8+T cells; While in AL patients CD8+CD28-Treg cells were positive correlation with CD8+T cells; Expression levels of peripheral blood CD8+CD28-Treg cells in ITP and AL patients were respectively no correlation with quantity of PTL and WBC. Immune dysfunction was easier to correct in ITP patients, AL followed.

Related Dissertations

  1. Analysis of Infrared Spectral Features and Identification of Al-responsive Genes in Small Black Soybean with Aluminum Stress,S529
  2. The Study on Cryopreservation and Mechanism of Freezing Injury on the Spermatozoa of Coelomactra Antiquate,S968.3
  3. Ke the micro Jun Treating Blood Diseases academic thinking, clinical experience and treatment of ITP medication law,R249
  4. BF-FCM Clustering Algorithm and Its Application in the Image Segmentation,TP391.41
  5. The Screening of the Rice Germplasm Resources on Al Tolerance and the Impact of Different Forms of N Element on Al Tolerance in Rice (Oryza sativa L.),S511
  6. The Clinical Evaluation of Measuring the Horizontal Sulcus to Sulcus Distance by Ultrasound Biomicroscopy,R770.4
  7. Bag-of-Visual Words for Image Categorization,TP391.41
  8. Study on Ecosystem Risk Management of Coal Mine Based on Fuzzy Cognitive-map and Stakeholders’ Participation,X322
  9. Research on Image Segmentation Method Based on Measure of Medium Truth Degree,TP391.41
  10. Thermal Cycle Stability of SOFC Seal Material,TM911.4
  11. Al Wire Bonding Failure and Automatic Optical Inspection on Power Device Leadframe,TG441
  12. Heat Treatment of Cast Al-Cu-Ti-(La) alloy microstructure and mechanical properties of,TG166.3
  13. Liquid Forging hypereutectic Al-Si alloy microstructure and properties,TG319
  14. Semi-solid / hot extruded hypereutectic Al-Fe alloy heat Mechanism,TG166.3
  15. AlTi refiner for Al-Mg 2 Si composite microstructure and mechanical properties of,TG27
  16. Al-Si-Cu-Nd cast aluminum alloy microstructure and fatigue properties,TG136.1
  17. Mg-Si alloy sheet Sc on Microstructure and Properties,TG146.2
  18. Extrusion Mg-Al-Zn-Y alloys Low Cycle Fatigue Behavior,TG379
  19. Squeeze casting hypereutectic Al-Si alloy microstructure and properties of,TG249.2
  20. Solid base catalysts and their catalytic synthesis reaction of isophorone Performance,TQ224.2
  21. SiCp / Al composites process and properties,TB332

CLC: > Medicine, health > Internal Medicine > Blood and lymphatic system diseases > Blood diseases > Hemorrhagic disease > Purpura
© 2012 www.DissertationTopic.Net  Mobile